BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33085842)

  • 41. Detection of the BRAF(V600E) mutation in fine needle aspiration cytology of thyroid papillary microcarcinoma cells selected by manual macrodissection: an easy tool to improve the preoperative diagnosis.
    Marchetti I; Iervasi G; Mazzanti CM; Lessi F; Tomei S; Naccarato AG; Aretini P; Alberti B; Di Coscio G; Bevilacqua G
    Thyroid; 2012 Mar; 22(3):292-8. PubMed ID: 22181337
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence of RET/PTC rearrangement in benign and malignant thyroid nodules and its clinical application.
    Guerra A; Sapio MR; Marotta V; Campanile E; Moretti MI; Deandrea M; Motta M; Limone PP; Fenzi G; Rossi G; Vitale M
    Endocr J; 2011; 58(1):31-8. PubMed ID: 21173509
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical implication of highly sensitive detection of the BRAF V600E mutation in fine-needle aspirations of thyroid nodules: a comparative analysis of three molecular assays in 4585 consecutive cases in a BRAF V600E mutation-prevalent area.
    Lee ST; Kim SW; Ki CS; Jang JH; Shin JH; Oh YL; Kim JW; Chung JH
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2299-306. PubMed ID: 22500044
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular profiling of thyroid nodule fine-needle aspiration cytology.
    Eszlinger M; Lau L; Ghaznavi S; Symonds C; Chandarana SP; Khalil M; Paschke R
    Nat Rev Endocrinol; 2017 Jul; 13(7):415-424. PubMed ID: 28361927
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differences in Thyroid Nodule Cytology and Malignancy Risk Between Children and Adults.
    Cherella CE; Angell TE; Richman DM; Frates MC; Benson CB; Moore FD; Barletta JA; Hollowell M; Smith JR; Alexander EK; Cibas ES; Wassner AJ
    Thyroid; 2019 Aug; 29(8):1097-1104. PubMed ID: 31298618
    [No Abstract]   [Full Text] [Related]  

  • 46. Pilot of BRAF mutation analysis in indeterminate, suspicious and malignant thyroid FNA cytology.
    Johnson SJ; Hardy SA; Roberts C; Bourn D; Mallick U; Perros P
    Cytopathology; 2014 Jun; 25(3):146-54. PubMed ID: 24417615
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical impact of a cytological screening system using cyclin D1 immunostaining and genomic analysis for the diagnosis of thyroid nodules.
    Teshima M; Tokita K; Ryo E; Matsumoto F; Kondo M; Ikegami Y; Shinomiya H; Otsuki N; Hiraoka N; Nibu KI; Yoshimoto S; Mori T
    BMC Cancer; 2019 Mar; 19(1):245. PubMed ID: 30885146
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Utility of shear wave elastography to detect papillary thyroid carcinoma in thyroid nodules: efficacy of the standard deviation elasticity.
    Kim HJ; Kwak MK; Choi IH; Jin SY; Park HK; Byun DW; Suh K; Yoo MH
    Korean J Intern Med; 2019 Jul; 34(4):850-857. PubMed ID: 29466846
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Triage of the indeterminate thyroid aspirate: What are the options for the practicing cytopathologist?
    Onenerk AM; Pusztaszeri MP; Canberk S; Faquin WC
    Cancer Cytopathol; 2017 Jun; 125(S6):477-485. PubMed ID: 28609009
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules.
    Nikiforov YE; Steward DL; Robinson-Smith TM; Haugen BR; Klopper JP; Zhu Z; Fagin JA; Falciglia M; Weber K; Nikiforova MN
    J Clin Endocrinol Metab; 2009 Jun; 94(6):2092-8. PubMed ID: 19318445
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Centralized molecular testing for oncogenic gene mutations complements the local cytopathologic diagnosis of thyroid nodules.
    Beaudenon-Huibregtse S; Alexander EK; Guttler RB; Hershman JM; Babu V; Blevins TC; Moore P; Andruss B; Labourier E
    Thyroid; 2014 Oct; 24(10):1479-87. PubMed ID: 24811481
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High risk of malignancy in cases with atypia of undetermined significance on fine needle aspiration of thyroid nodules even after exclusion of NIFTP.
    Ă–zkara SK; Bayrak BY; Turan G
    Diagn Cytopathol; 2020 Nov; 48(11):986-997. PubMed ID: 32745375
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of BRAFV600E mutation analysis and second cytologic review of fine-needle aspiration for evaluating thyroid nodule.
    Kang G; Cho EY; Shin JH; Chung JH; Kim JW; Oh YL
    Cancer Cytopathol; 2012 Feb; 120(1):44-51. PubMed ID: 21751431
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The natural history of the benign thyroid nodule: what is the appropriate follow-up strategy?
    Ajmal S; Rapoport S; Ramirez Batlle H; Mazzaglia PJ
    J Am Coll Surg; 2015 Jun; 220(6):987-92. PubMed ID: 25667137
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification and Development of a Lung Adenocarcinoma PDX Model With STRN-ALK Fusion.
    Ren H; Hou X; Eiken PW; Zhang J; Pierson KE; Nair AA; Davila JI; Kovarikova H; Jang JS; Johnson SH; Molina JR; Marks RS; Yang P; Yi JE; Mansfield AS; Jen J
    Clin Lung Cancer; 2019 Mar; 20(2):e142-e147. PubMed ID: 30581091
    [No Abstract]   [Full Text] [Related]  

  • 56. Effect of BRAF V600E mutation detection of fine-needle aspiration biopsy on diagnosis and treatment guidance of papillary thyroid carcinoma.
    Qi W; Shi C; Zhang P; Feng L; Wang J; Chen D
    Pathol Res Pract; 2020 Aug; 216(8):153037. PubMed ID: 32703500
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    Li J; Yin Y; Huang H; Li M; Li H; Zhang M; Jiang C; Yang R
    Epigenomics; 2023 Dec; 15(23):1257-1272. PubMed ID: 38126720
    [No Abstract]   [Full Text] [Related]  

  • 58. Implications of a suspicious afirma test result in thyroid fine-needle aspiration cytology: an institutional experience.
    Lastra RR; Pramick MR; Crammer CJ; LiVolsi VA; Baloch ZW
    Cancer Cytopathol; 2014 Oct; 122(10):737-44. PubMed ID: 25123499
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A morpho-molecular diagnosis of papillary thyroid carcinoma: BRAF V600E detection as an important tool in preoperative evaluation of fine-needle aspirates.
    Marchetti I; Lessi F; Mazzanti CM; Bertacca G; Elisei R; Coscio GD; Pinchera A; Bevilacqua G
    Thyroid; 2009 Aug; 19(8):837-42. PubMed ID: 19534623
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Novel Risk Stratification System for Thyroid Nodules With Indeterminate Cytology-A Pilot Cohort Study.
    Gomes-Lima CJ; Auh S; Thakur S; Zemskova M; Cochran C; Merkel R; Filie AC; Raffeld M; Patel SB; Xi L; Wartofsky L; Burman KD; Klubo-Gwiezdzinska J
    Front Endocrinol (Lausanne); 2020; 11():53. PubMed ID: 32132976
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.